Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in BCTX — BriaCell Therapeutics Corp.

CIK 1000275 TORONTO, A6
Back to BCTX Full portfolio

Position in BCTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$936
+$517 QoQ
Shares Held
289
+189.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 18 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. BCTX ranks #365 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in BCTX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $936 289
2026-03-31 $419 100
2025-12-31 $711 100
2025-09-30 $1,100 100
2025-06-30 $3,142 1,069
2025-03-31 $3,650 1,000
2024-09-30 $4,728 3,813
2024-06-30 $4,368 3,832
2024-03-31 $10,296 3,600
2023-12-31 $108,810 18,600
2023-09-30 $22,500 3,600